Tofacitinib Acid Impurity
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

2328165-36-0Tofacitinib Acid Impurity

● 재고 있음

카탈로그 번호:VE008140
CAS 번호:2328165-36-0
분자식:C16H21N5O3
분자량:331.37 g/mol

에 대한 추가 정보 CAS 2328165-36-0

모약물

Tofacitinib

IUPAC명

3-((3R, 4R)-4-Methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic Acid

약전 동의어

N/A

Other Synonyms

Tofacitinib Inhouse Impurity K

SMILES

O=C(O)CC(N1C[C@H](N(C)C2=C3C(NC=C3)=NC=N2)[C@H](C)CC1)=O

InChI

InChI=1S/C16H21N5O3/c1-10-4-6-21(13(22)7-14(23)24)8-12(10)20(2)16-11-3-5-17-15(11)18-9-19-16/h3,5,9-10,12H,4,6-8H2,1-2H3,(H,23,24)(H,17,18,19)/t10-,12+/m1/s1

설명

Tofacitinib Acid Impurity, also known as Tofacitinib Inhouse Impurity K is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of. Tofacitinib Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications.” Tofacitinib Acid Impurity (CAS No: 2328165-36-0) Or 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic Acid, Tofacitinib Acid is an Impurity Tofacitinib, Tofacitinib is Janus kinase inhibitor, used in the treatment of renal transplantation, rheumatoid arthritis, psoriasis, and ulcerative colitis.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url